ISSN 2575-6206
Vol. 6, Issue 1, 2022January 09, 2022 CDT
Prodrugs: A Comparison of o-Nitrobenzyl, p-Hydroxyphenacyl, and Coumarin Photoremovable Protecting Groups and Their In Vivo Applications in Cancer Therapy
Prodrugs: A Comparison of o-Nitrobenzyl, p-Hydroxyphenacyl, and Coumarin Photoremovable Protecting Groups and Their In Vivo Applications in Cancer Therapy
Articles in Vol. 6, Issue 1, 2022
Vol. 6, Issue 1, 2022
- Immunotherapy using CRISPR-Cas9 systems to treat rheumatoid arthritis with PTPN22 R620W mutations and target PD-1 and CD20Aishwarya ShivaramanNicole Guilz
- Gender disparity in the incidence of childhood central nervous system cancers among different Asian Pacific Islander populationsAlistair Lam
- Dimensionality reduction of the freedoms constituting The Index of Economic Freedom.Eric Cui
- Sentiment Analysis on Tweets in the 2020 US Presidential ElectionArmaan Chandak
- Natural product polyphenol inhibition of amyloid-β aggregationVarsha BeldonaAyush PatelKavya PatelNeha AbrahamAlyssa HalvorsenAshlee LiuNandini MannemGayathri Renganathan
- Prodrugs: A Comparison of o-Nitrobenzyl, p-Hydroxyphenacyl, and Coumarin Photoremovable Protecting Groups and Their In Vivo Applications in Cancer TherapyEmma Ka
- COVID-19 Variants: A Structural and Functional Analysis of Spike ProteinsHarshni P PatelMicki ZhengRakhi AgarwalNadia MakarJennifer DonnellyMina Armani
Ka, Emma. 2022. “Prodrugs: A Comparison of o-Nitrobenzyl, p-Hydroxyphenacyl, and Coumarin Photoremovable Protecting Groups and Their In Vivo Applications in Cancer Therapy.” Journal of High School Science 6 (1). https://doi.org/10.64336/001c.31703.